Tildrakizumab Side Effects

Medically reviewed by Philip Thornton, DipPharm. Last updated on Sep 17, 2024.

Applies to tildrakizumab: subcutaneous solution.

Precautions

It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to check for unwanted effects.

You will need to have a skin test for tuberculosis before you start receiving this medicine. Tell your doctor if you or anyone in your home has ever had a positive reaction to a tuberculosis skin test.

This medicine may cause serious allergic reactions, including angioedema, which can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have a rash, itching, or large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals after receiving this medicine.

It is important to check with your doctor if you have any symptoms of an infection, such as fever or chills, cough or hoarseness, lower back or side pain, painful or difficult urination.

Do not have any live vaccines (immunizations) while you are being treated with this medicine. Ask your doctor if you have any concerns.

Serious side effects of tildrakizumab

Along with its needed effects, tildrakizumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking tildrakizumab:

Other side effects of tildrakizumab

Some side effects of tildrakizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to tildrakizumab: subcutaneous solution.

Hypersensitivity adverse events

• Frequency not reported: Hypersensitivity, angioedema, urticaria^[Ref]

Immunologic

• Very common (10% or more): Infections (e.g., upper respiratory tract infection) (23%)^[Ref]

Local

• Common (1% to 10%): Injection site reactions (e.g., injection site urticaria, pruritus, pain, reaction, erythema, inflammation, edema, swelling, bruising, hematoma, hemorrhage)^[Ref]

Respiratory

• Very common (10% or more): Upper respiratory tract infections (e.g., nasopharyngitis, upper respiratory tract infection, viral upper respiratory tract infection, pharyngitis) (14%)^[Ref]

See also:

Frequently asked questions

• Skyrizi vs Ilumya. What’s the difference?
• Does Ilumya treat psoriatic arthritis?
• How does Ilumya compare to other treatments?
• How long does it take Ilumya to work?
• How does Ilumya affect my immune system?
• What are the new drugs for plaque psoriasis?

Further information

Tildrakizumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer